Caliber Imaging & Diagnostics Appoints Steven M. Ridge and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Caliber Imaging & Diagnostics Appoints Steven M. Ridge and Ben J. Alexander as Regional Sales Managers for West and Midwest

BOSTON and ROCHESTER, N.Y., Nov. 20, 2013 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has appointed Steven M. Ridge as Midwestern Regional Sales Manager and Ben J. Alexander as Western Regional Sales Manager, both newly created positions. Each will be focused on further developing the Company's sales initiatives for its VivaScope ® platform in the West and Midwest regions of the United States. The FDA-cleared VivaScope ® devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties.

L. Michael Hone, Chief Executive Officer of Caliber I.D., said, "As a part of our ongoing efforts to expand Caliber I.D.'s footprint within the U.S. healthcare market, it is imperative that we bolster the Company's regional sales initiatives and increase our sales force. I am very pleased that Steven Ridge and Ben Alexander, both industry veterans, have agreed to join our team to oversee our sales efforts in the West and Midwest. Steve and Ben's experience make them ideal candidates to sell into a market consisting of physicians; pharmaceutical, cosmeceutical and skincare product development companies; government agencies; academic institutions; and anyone doing research on skin at the cellular level."

Mr. Ridge has more than 30 years of biomedical sales experience. He most recently served as Bioscience Sales Specialist-Midwest Region at Nikon Instruments Inc. Prior to this, he was VP of Marketing for three divisions within Roper Industries' Imaging Group, where he produced $10M in new sales by introducing globally nine new products to market in two years. Earlier, he held various sales and marketing positions at a series of companies including Fryer Company Inc. and Leica Microsystems Inc. He holds a BS degree from Iowa State University.

Mr. Alexander has nearly 30 years experience in sales and biomedical research. He most recently served as Technical Microscopy Specialist at McBain Systems/Leica Microsystems, where he represented the companies' industrial, forensic and educational accounts in Southern California. Among his accomplishments, he increased territory sales by 20 percent in 2012. Prior to this, he served as Western Territory Manager at Biolog, Inc. Earlier, he held sales positions at Thermo Electron Corp. (now ThermoFisher) and ISC BioExpress. He holds a BS degree from the University of Texas at Austin.

About Caliber Imaging & Diagnostics

Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. The FDA-cleared VivaScope ® devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties. VivaScope ® is a registered trademark of Caliber Imaging & Diagnostics. For more information about Caliber I.D. and its products, please visit www.caliberid.com .

Safe Harbor

This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.

Richard Pulsifer Chief Financial Officer (617) 348-9821 Investor Relations: Dian Griesel Int'l. Cheryl Schneider (212) 825-3210 Public Relations: Dian Griesel Int'l. Susan Forman or Laura Radocaj (212) 825-3210

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 0

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 0

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 1

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 0

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
TomoIQ Unveils Money Finder at Money20/20 Event

Updated Category News Views 0

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 0

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Jovani's Innovative Approach to Affordable Sustainable Fashion

Updated Category News Views 253

Understanding Gen Z's Fashion Preferences Young consumers today are navigating a complex landscape of fashion choices, often caught between the desire for quality and the struggle with affordability. A recent trend highlights this dilemma within Generation Z, where the majority prioritize sustainability but consistently return to fast fashion options due to lower prices....

Continue Reading
Steve Cohen Shifts Focus to Growth at Point72 Asset Management

Updated Category News Views 217

Steve Cohen's New Direction at Point72 Asset Management In a major development reported by Bloomberg News, billionaire Steve Cohen, founder of Point72 Asset Management, has made the notable decision to step back from active trading. This strategic change aims to bolster the firm's growth trajectory and adapt to the shifting landscape of asset management. Mentoring Future...

Continue Reading
Opportunity for Methode Electronics, Inc. Investors to Join Class Action

Updated Category News Views 125

Class Action Lawsuit Filed for Methode Electronics, Inc. Investors Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm specializing in investor rights, has announced that a class action lawsuit has been filed against Methode Electronics, Inc. (NYSE: MEI) and its management team. This lawsuit is particularly important for investors who may have experienced...

Continue Reading
NORBIT ASA Proposes NOK 3.00 Dividend for 2024 Fiscal Year

Updated Category News Views 268

NORBIT ASA Announces Proposed Cash Dividend NORBIT ASA has made an important announcement regarding the proposed cash dividend to be paid to its shareholders. As part of their ongoing commitment to return value to investors, the board of directors has put forth a resolution suggesting a dividend of NOK 3.00 per share for the fiscal year 2024. This proposal will be...

Continue Reading
Settlement Reached for Pilgrim's Pride Corporation Investors

Updated Category News Views 311

Understanding the Proposed Settlement for Pilgrim's Pride Corporation A notable development has emerged regarding the Pilgrim's Pride Corporation and its securities, which will impact everyone who has bought or otherwise acquired shares in the company. A proposed settlement has been announced, aiming to provide clarity and potential compensation for affected investors....

Continue Reading